Wechselwirkungen · Fycompa
Fycompa 2 mg film-coated tablets Fycompa 4 mg film-coated tablets Fycompa 6 mg film-coated tablets Fycompa 8 mg film-coated tablets Fycompa 10 mg film-coated tablets Fycompa 12 mg film-coated tablets · Abschnitt 4.5 · PDF-Seite 9–10
HOS-125863 · Präparat HOS-096179
9 (2-fold), which are known inducers of enzymes of metabolism (see section 5.2). This effect should be taken into account and managed when adding or withdrawing these anti-epileptic drugs from a patient’s treatment regimen. Clonazepam, levetiracetam, phenobarbital, topiramate, zonisamide, clobazam, lamotrigine and valproic acid did not affect to a clinically relevant manner the clearance of Fycompa.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): lamotrigine (HOS-086242) zonisamide (HOS-113349) topiramate (HOS-110310) phenobarbital (HOS-085617) valproic acid (HOS-088515) clonazepam (HOS-116372) clobazam (HOS-115305) levetiracetam (HOS-090742)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-05-26T10:26:00Z · SHA-256 b5542bbc20a489b9730fd4bf2ab7b210c2adb03b3f707d2db6edd804a3f94228 · Passage e745f17825e615006ee5ebd992b92d6720733933f295bdbde789d0951a9fb36b · Zeichen 3027–3430 im Abschnitt